1. Home
  2. SPRY vs GAM Comparison

SPRY vs GAM Comparison

Compare SPRY & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • GAM
  • Stock Information
  • Founded
  • SPRY 2015
  • GAM 1927
  • Country
  • SPRY United States
  • GAM United States
  • Employees
  • SPRY N/A
  • GAM N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • GAM Investment Managers
  • Sector
  • SPRY Health Care
  • GAM Finance
  • Exchange
  • SPRY Nasdaq
  • GAM Nasdaq
  • Market Cap
  • SPRY 1.6B
  • GAM 1.3B
  • IPO Year
  • SPRY N/A
  • GAM N/A
  • Fundamental
  • Price
  • SPRY $17.88
  • GAM $56.85
  • Analyst Decision
  • SPRY Strong Buy
  • GAM
  • Analyst Count
  • SPRY 4
  • GAM 0
  • Target Price
  • SPRY $28.75
  • GAM N/A
  • AVG Volume (30 Days)
  • SPRY 1.6M
  • GAM 20.1K
  • Earning Date
  • SPRY 08-05-2025
  • GAM 01-01-0001
  • Dividend Yield
  • SPRY N/A
  • GAM 5.74%
  • EPS Growth
  • SPRY N/A
  • GAM N/A
  • EPS
  • SPRY N/A
  • GAM 11.67
  • Revenue
  • SPRY $97,122,000.00
  • GAM N/A
  • Revenue This Year
  • SPRY N/A
  • GAM N/A
  • Revenue Next Year
  • SPRY $170.64
  • GAM N/A
  • P/E Ratio
  • SPRY N/A
  • GAM $3.95
  • Revenue Growth
  • SPRY 971120.00
  • GAM N/A
  • 52 Week Low
  • SPRY $8.91
  • GAM $37.32
  • 52 Week High
  • SPRY $18.90
  • GAM $46.48
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 60.97
  • GAM 71.72
  • Support Level
  • SPRY $16.40
  • GAM $56.23
  • Resistance Level
  • SPRY $18.05
  • GAM $57.54
  • Average True Range (ATR)
  • SPRY 1.06
  • GAM 0.72
  • MACD
  • SPRY 0.03
  • GAM 0.05
  • Stochastic Oscillator
  • SPRY 62.54
  • GAM 78.30

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About GAM General American Investors Inc.

General American Investors Co Inc is a closed-end, diversified management investment company. The primary investment objective of the company is long-term capital appreciation through investment in companies with above-average growth potential. It focuses on equity securities with growth potential at reasonable valuations.

Share on Social Networks: